| 000 | 01560 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515163346.0 | ||
| 264 | 0 | _c20090716 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1778-7254 | ||
| 024 | 7 |
_a10.1016/j.jbspin.2008.10.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMavrogenis, Andreas F | |
| 245 | 0 | 0 |
_aLate Mycobacterium bovis spondylitis after intravesical BCG therapy. _h[electronic resource] |
| 260 |
_bJoint bone spine _cMay 2009 |
||
| 300 |
_a296-300 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Intravesical |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBCG Vaccine _xadverse effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEpidural Abscess _xetiology |
| 650 | 0 | 4 |
_aEthambutol _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoniazid _xtherapeutic use |
| 650 | 0 | 4 |
_aLumbar Vertebrae _xpathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMycobacterium bovis _xisolation & purification |
| 650 | 0 | 4 |
_aOsteolysis _xetiology |
| 650 | 0 | 4 |
_aOsteomyelitis _xetiology |
| 650 | 0 | 4 |
_aRifampin _xtherapeutic use |
| 650 | 0 | 4 | _aSpinal Fusion |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTuberculosis, Spinal _xetiology |
| 700 | 1 | _aSakellariou, Vasileios I | |
| 700 | 1 | _aTsiodras, Sotirios | |
| 700 | 1 | _aPapagelopoulos, Panayiotis J | |
| 773 | 0 |
_tJoint bone spine _gvol. 76 _gno. 3 _gp. 296-300 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jbspin.2008.10.011 _zAvailable from publisher's website |
| 999 |
_c18741277 _d18741277 |
||